Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry

Kristian Thidemann Andersen; Tobias Klausen; Niels Abildgaard; Mette Klarskov Andersen; Niels Frost Andersen; Ulf Christian Frølund; Carsten Helleberg; Eigil Kjeldsen; Per Pedersen; Sissel Helm-Petersen; Asta Svirskaite; Birgitte Preiss; Peter Gimsing; Annette Juul Vangsted

doi:10.1002/ajh.24857

Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry

Kristian Thidemann Andersen, Tobias Klausen, Niels Abildgaard, Mette Klarskov Andersen, Niels Frost Andersen, Ulf Christian Frølund, Carsten Helleberg, Eigil Kjeldsen, Per Pedersen, Sissel Helm-Petersen, Asta Svirskaite, Birgitte Preiss, Peter Gimsing, Annette Juul Vangsted

Institut for Klinisk Medicin

5 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	American Journal of Hematology
Vol/bind	92
Udgave nummer	10
Sider (fra-til)	E611-E614
ISSN	0361-8609
DOI	https://doi.org/10.1002/ajh.24857
Status	Udgivet - okt. 2017

Adgang til dokumentet

10.1002/ajh.24857

ajh.24857Forlagets udgivne version, 460 KB

Citationsformater

Thidemann Andersen, K., Klausen, T., Abildgaard, N., Klarskov Andersen, M., Frost Andersen, N., Christian Frølund, U., Helleberg, C., Kjeldsen, E., Pedersen, P., Helm-Petersen, S., Svirskaite, A., Preiss, B., Gimsing, P., & Juul Vangsted, A. (2017). Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry. American Journal of Hematology, 92(10), E611-E614. https://doi.org/10.1002/ajh.24857

Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry. / Thidemann Andersen, Kristian; Klausen, Tobias; Abildgaard, Niels et al.
I: American Journal of Hematology, Bind 92, Nr. 10, 10.2017, s. E611-E614.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning

Thidemann Andersen, K, Klausen, T, Abildgaard, N, Klarskov Andersen, M, Frost Andersen, N, Christian Frølund, U, Helleberg, C, Kjeldsen, E, Pedersen, P, Helm-Petersen, S, Svirskaite, A, Preiss, B, Gimsing, P & Juul Vangsted, A 2017, 'Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry', American Journal of Hematology, bind 92, nr. 10, s. E611-E614. https://doi.org/10.1002/ajh.24857

Thidemann Andersen K, Klausen T, Abildgaard N, Klarskov Andersen M, Frost Andersen N, Christian Frølund U et al. Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry. American Journal of Hematology. 2017 okt.;92(10):E611-E614. doi: 10.1002/ajh.24857

@article{74db4ee9139b4ccaa10e36cc10946483,

title = "Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry",

keywords = "Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Autografts, Bortezomib/administration & dosage, Cyclophosphamide/administration & dosage, Denmark/epidemiology, Dexamethasone/administration & dosage, Disease-Free Survival, Female, Humans, Male, Middle Aged, Multiple Myeloma/genetics, Registries, Stem Cell Transplantation, Survival Rate, Thalidomide/administration & dosage",

author = "{Thidemann Andersen}, Kristian and Tobias Klausen and Niels Abildgaard and {Klarskov Andersen}, Mette and {Frost Andersen}, Niels and {Christian Fr{\o}lund}, Ulf and Carsten Helleberg and Eigil Kjeldsen and Per Pedersen and Sissel Helm-Petersen and Asta Svirskaite and Birgitte Preiss and Peter Gimsing and {Juul Vangsted}, Annette",

year = "2017",

month = oct,

doi = "10.1002/ajh.24857",

language = "English",

volume = "92",

pages = "E611--E614",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "JohnWiley & Sons, Inc.",

number = "10",

}

TY - JOUR

T1 - Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation

T2 - A study based on the nationwide Danish Multiple Myeloma Registry

AU - Thidemann Andersen, Kristian

AU - Klausen, Tobias

AU - Abildgaard, Niels

AU - Klarskov Andersen, Mette

AU - Frost Andersen, Niels

AU - Christian Frølund, Ulf

AU - Helleberg, Carsten

AU - Kjeldsen, Eigil

AU - Pedersen, Per

AU - Helm-Petersen, Sissel

AU - Svirskaite, Asta

AU - Preiss, Birgitte

AU - Gimsing, Peter

AU - Juul Vangsted, Annette

PY - 2017/10

Y1 - 2017/10

KW - Adult

KW - Aged

KW - Antineoplastic Combined Chemotherapy Protocols/administration & dosage

KW - Autografts

KW - Bortezomib/administration & dosage

KW - Cyclophosphamide/administration & dosage

KW - Denmark/epidemiology

KW - Dexamethasone/administration & dosage

KW - Disease-Free Survival

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Multiple Myeloma/genetics

KW - Registries

KW - Stem Cell Transplantation

KW - Survival Rate

KW - Thalidomide/administration & dosage

U2 - 10.1002/ajh.24857

DO - 10.1002/ajh.24857

M3 - Comment/debate

C2 - 28707398

SN - 0361-8609

VL - 92

SP - E611-E614

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 10

ER -